CD274 and B-cell chronic lymphocytic leukemia: PD-L1 overexpression on the surface of CLL cells downregulates T cell activation and promotes immune tolerance via intracellular pathways through the interaction with PD-1 exposed on the cell membrane of T cells [13,59].